The olfactory bulb (OB) is affected early in both Parkinson's (PD) and Alzheimer's disease (AD), evidenced by the presence of disease-specific protein aggregates and an early loss of olfaction. Whereas previous studies showed amoeboid microglia in the classically affected brain regions of PD and AD patients, little was known about such changes in the OB. Using a morphometric approach, a significant increase in amoeboid microglia density within the anterior olfactory nucleus (AON) of AD and PD patients was observed. These amoeboid microglia were in close apposition to beta-amyloid, hyperphosphorylated tau or alpha-synuclein deposits, but no uptake of pathological proteins by microglia could be visualized. Subsequent analysis showed 1) no cor...
Olfactory dysfunction is one of the earliest features in Lewy-type alphasynucleinopathies (LTS) such...
Hyposmia is common in Alzheimer's dementia (AD) and Parkinson's disease dementia (PDD). We evaluated...
Early olfactory dysfunction has been consistently reported in both Alzheimer’s disease (AD) and in t...
The olfactory bulb (OB) is affected early in both Parkinson's (PD) and Alzheimer's disease (AD), evi...
The olfactory bulb (OB) shows early neuropathological hallmarks in numerous neurodegenerative diseas...
Alzheimer's disease (AD) is the most prevalent form of dementia. Key AD symptoms include memory and ...
The olfactory bulbs have been examined in patients with Alzheimer's disease and compared with those ...
BACKGROUND: In Alzheimer's disease (AD) the olfactory system, including the olfactory bulb, a limbic...
SUMMARY The olfactory bulbs have been examined in patients with Alzheimer's disease and compare...
BackgroundHyposmia in Alzheimer's disease (AD) is a typical early symptom according to numerous prev...
Olfactory neuropathology is a cause of olfactory loss in Alzheimer's disease (AD). Olfactory dysfunc...
Immunolocalization of apolipoprotein Ε (apoE) was investigated in human olfactory mucosa in which ol...
Background: Olfactory dysfunction is present since the earliest stage of Alzheimer's disease (AD). ...
Olfactory dysfunction is present in up to 90% of Alzheimer's disease (AD) patients. Although deposit...
Olfactory dysfunction is among the earliest features of Alzheimer's disease (AD). Although neuropath...
Olfactory dysfunction is one of the earliest features in Lewy-type alphasynucleinopathies (LTS) such...
Hyposmia is common in Alzheimer's dementia (AD) and Parkinson's disease dementia (PDD). We evaluated...
Early olfactory dysfunction has been consistently reported in both Alzheimer’s disease (AD) and in t...
The olfactory bulb (OB) is affected early in both Parkinson's (PD) and Alzheimer's disease (AD), evi...
The olfactory bulb (OB) shows early neuropathological hallmarks in numerous neurodegenerative diseas...
Alzheimer's disease (AD) is the most prevalent form of dementia. Key AD symptoms include memory and ...
The olfactory bulbs have been examined in patients with Alzheimer's disease and compared with those ...
BACKGROUND: In Alzheimer's disease (AD) the olfactory system, including the olfactory bulb, a limbic...
SUMMARY The olfactory bulbs have been examined in patients with Alzheimer's disease and compare...
BackgroundHyposmia in Alzheimer's disease (AD) is a typical early symptom according to numerous prev...
Olfactory neuropathology is a cause of olfactory loss in Alzheimer's disease (AD). Olfactory dysfunc...
Immunolocalization of apolipoprotein Ε (apoE) was investigated in human olfactory mucosa in which ol...
Background: Olfactory dysfunction is present since the earliest stage of Alzheimer's disease (AD). ...
Olfactory dysfunction is present in up to 90% of Alzheimer's disease (AD) patients. Although deposit...
Olfactory dysfunction is among the earliest features of Alzheimer's disease (AD). Although neuropath...
Olfactory dysfunction is one of the earliest features in Lewy-type alphasynucleinopathies (LTS) such...
Hyposmia is common in Alzheimer's dementia (AD) and Parkinson's disease dementia (PDD). We evaluated...
Early olfactory dysfunction has been consistently reported in both Alzheimer’s disease (AD) and in t...